EUVIMEDEUVIMED entdecken
Crossref

Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing

June Tome, Kanika Sehgal, Amrit K Kamboj, William S Harmsen, Sahil Khanna, Darrell S Pardi

Clinical Gastroenterology and Hepatology · 2023-11 · 21 (12) · 3125-3131.e2

DOI: 10.1016/j.cgh.2023.04.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-11. Verfasst von June Tome und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: Bile Acids and Salts, Colitis, Microscopic. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Bile acid sequestrants (BAS) may be a treatment in microscopic colitis (MC), but efficacy data are limited. We evaluated the effectiveness of BAS in MC and assessed the utility of bile acid testing to predict response. METHODS: Adults with MC treated with BAS (2010-2020) at Mayo Clinic were identified. Bile acid malabsorption was defined by elevated serum 7⍺-hydroxy-4-cholesten-3-one or by fecal testing using previously validated cutoffs. Response was defined at 12 ± 4 weeks after BAS initiation as: complete (resolution of diarrhea), partial (≥50% improvement in diarrhea), nonresponse (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bile Acids and SaltsColitis, MicroscopicAdultHumansFemaleMiddle AgedMaleCholestyramine ResinDiarrheaColestipol

Stichwörter der Autor:innen

Bile Acid SequestrantsCollagenous ColitisLymphocytic ColitisMicroscopic Colitis

Substanzen

Bile Acids and SaltsCholestyramine ResinColestipol

Autor:innen und Institutionen

  • Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
  • Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
  • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: pardi.darrell@mayo.edu.

Zitieren

APA

Tome, J., Sehgal, K., Kamboj, A. K., Harmsen, W. S., Khanna, S., & Pardi, D. S. (2023). Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing. Clinical Gastroenterology and Hepatology, 21(12), 3125-3131.e2. https://doi.org/10.1016/j.cgh.2023.04.031

Vancouver

Tome J, Sehgal K, Kamboj AK, Harmsen WS, Khanna S, Pardi DS. Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing. Clinical Gastroenterology and Hepatology. 2023;21(12):3125-3131.e2. doi:10.1016/j.cgh.2023.04.031

BibTeX
@article{Tome2023,
  author = {Tome, June and Sehgal, Kanika and Kamboj, Amrit K and Harmsen, William S and Khanna, Sahil and Pardi, Darrell S},
  title = {Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2023},
  volume = {21},
  number = {12},
  pages = {3125--3131.e2},
  doi = {10.1016/j.cgh.2023.04.031}
}
Kostenlos starten →